Screening for memory disorders, dementia and Alzheimer's disease

Aging Health

Volumn 4, Issue 4, 2008, Pages 399-432

  Ashford, J Wesson ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Alzheimer's disease; Cognitive; Dementia; Item response theory; Memory; Mental; Mini mental state; Modern test theory; Neuropsychology; Screening

Indexed keywords

ALZHEIMER DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE DEFECT; COST BENEFIT ANALYSIS; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FALSE POSITIVE RESULT; HUMAN; INCIDENCE; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEMORY DISORDER; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; SCREENING; SHORT PORTABLE MENTAL STATUS QUESTIONNAIRE; WECHSLER INTELLIGENCE SCALE;

EID: 50849132608     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/1745509X.4.4.399     Document Type: Review

References (260)

1. Ashford J, Borson S, O'Hara R et al.: Should older adults be screened for dementia? Alzheimers Dement. 2, 76-85 (2006).
2. DeKosky S, McConnell S, Branche C et al.: Guidelines for the development of community-based community-based screening programs for cognitive impairment in older people. Alzheimer Insights 7, 3 (2001).
3. Ashford J, Borson S, O'Hara R et al.: Should older adults be screened for dementia? It is important to screen for evidence of dementia. Alzheimers Dement. 3, 75-80 (2007).
4. Ashford J, Kraemer H, Tinklenberg J et al.: Statistical and pharmacoeconomic issues for Atzheimer's screening. Alzheimers Dement. 3, 126 (2007).
5. Frank L. Reply. Alzheimers Dement. 3, 127-128 (2007).
6. U.S. Preventive Services Task Force U: Screening for depression: recommendations and rationale. Am. Fam. Physician 66(4), 647-650 (2002).
7. Getsios D, Migliaccio-Walle K, Caro JJ: NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used? Pharmaroeconomics 25(12), 997-1006 (2007).
8. Petersen RC, Smith GE, Waring SC et al.: Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56(3), 303-308 (1999).
9. Flicker C, Ferris SH, Reisberg B: Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41(7), 1006-1009 (1991).
10. Petersen RC, Bennett D: Mild cognitive impairment: is it Alzheimer's disease or not? J. Alzheimers Dis. 7(3), 241-245; discussion 255-262 (2005).
11. Morris JC, Cummings J: Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J. Alzheimers Dis. 7(3), 235-239; discussion 255-262 (2005).
12. Plassman BL, Langa KM, Fisher GG et al.: Prevalence of cognitive impairment without dementia in the United States. Ann. Intern. Med. 148(6), 427-434 (2008).
13. Yesavage JA, O'Hara F, Kraemer H et al.: Modeling the Prevalence and incidence of Alzheimer's disease and mild cognitive impairment. J. Psychiatr. Res. 36(5), 281-286 (2002).
14. Carpenter BD, Xiong C, Porensky EK et al.: Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment. J. Am. Geriatr. Soc. 56(3), 405-412 (2008).
15. American Psychiatric Association: Diagnostic and Statistical Manual, 4th revision (1994).
16. American Psychological Assocition: Guidelines for the evaluation of dementia and age-related cognitive decline, APA Presidential Task Force on the assessment of age-consistent memory decline and dementia (1998).
17. McKhann G, Drachman D, Folstein M et al.: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7), 939-944 (1984).
18. Mansdorf IJ, Harrington M, Lund J, Wohl N: Netuopsychological tesung in skilled nursing facilities: the failure to confirm diagnoses of dementia. J. Am. Med. Dir. Assoc. 9(4); 271-274 (2008).
19. Poon L: Clinical Memory Assessment of Older Adults. American Psychological Association, Wishington, DC, USA (1986).
20. Grundman M, Petersen RC, Ferris SH et al.: Mild cognitive impairment can be distinguished from Alzheimer disease and normal agaig for clinical trials. Arch. Neurol. 61(1), 59-66 (2004).
21. Ashford JW, Kolm P, Colliver JA, Bekian C, Hsu LN: Alzheimer patient evaluation and the mini-mental state: item characteristic curve analysis. J. Gerontol. 44(5), P139-P146 (1989).
22. Weiss D, Yoes M: Item response theory. In: Advances in Educational and Psychological Testing: Theory and Applications. Kluwer Academic Publishers, Boston, MA, USA 69-95 (1991).
23. Hambleton R. Swaminathan H, Rogers H: Fundamentals of Item Response Theory. Sage Publications, New Bury Park, CA, USA (1999).
24. Yen M, Edwardson SR: Item-response theory approach in scale development. Nurs. Res. 48(4), 234-238 (1999).
25. Embretson S, Reise S: Item Reponse Theory for Psychologists. Lawrence Edbaum Associates, Inc. Mahwah, NJ, USA (2000).
26. Reise SR, Haviland MG: Item response theory and the measurement of clinical change. J. Pers. Assess. 84(3), 228-238 (2005).
27. Mendiondo MS, Ashford JW, Kryscio RJ, Schmitt FA: Designing a Brief Alzheimer Screen (BAS). J. Alzheimers Dis. 5(5), 391-398 (2003).
28. Folstein MF, Folstein SE, McHugh PR: Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12(3), 189-198 (1975).
29. Halstead H: A psychometric study of senility. J. Ment. Sci. 89, 363-373 (1943).
30. Denny-Brown D: Handbook of Neurological Examination and Case Recording. Harvard University Press, Cambridge, MA. USA 1946, 1967.
31. Kahn RL, Goldfarb AI, Pollack M, Peck A: Brief objective measures for the determination of mental status in the aged. Am. J. Psychiatry 117, 326-328 (1960).
32. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114(512), 797-811 (1968).
33. Hodkinson HM: Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1(4), 233-238 (1972).
34. Mattis S: Dementia Rating Scale Professional Manual. Psychological Assessment Resources, Odessa, FL, USA (1973).
35. Mattis S: Mental status examination for organic mental syndrome in the elderly In: Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. Grune & Stratton, NY, USA (1976).
36. Hasegawa K: Psychology of the aged patient and the nursing approach. Kangogaku Zasshi 38(8), 893-900 (1974).
37. Pattie AH, Gilleard CJ: A brief psychogeriatric assessment schedule. Validation against psychiatric diagnosis and discharge from hospital. Br. J. Psychiatry 127, 489-493 (1975).
38. Pfeiffer E: A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23(10), 433-441 (1975).
39. Kane R, Kane R: Assessing the Elderly. Lexington Books, Lexington, MA, USA (1981).
40. Irving G, Robinson RA, McAdam W: The validity of some cognitive tests in the diagnosis of dementia. Br. J. Psychiatry 117(537), 149-156 (1970).
41. Folstein M: The birth of the MMS. This Week's Citation Classic. 2, 18 (1990).
42. Schmitt FA, Ranseen JD, DeKosky ST: Cognitive mental status examinations. Clin. Geriatr. Med. 5(3), 545-564 (1989).
43. Tangalos EG, Smith GE, Ivnik RJ et al.: The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin. Proc. 71(9), 829-837 (1996).
44. Malloy PF, Cummings JL, Coffey CE et al.: Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. J. Neuropsychiatry Clin. Neurosci. 9(2), 189-197 (1997).
45. Tombaugh TN, McIntyre NJ: The mini-mental state examination: a comprehensive review. J. Am. Geriatr. Soc. 40(9), 922-935 (1992).
46. Wells C: Dementia. FA Davis Co., Philadelphia, PA, USA (1971).
47. Powsner S, Powsner D: Cognition, copyright, and the classroom. Am. J. Psychiatry 162(3), 627-628 (2005).
48. Ashford JW, Kumar V, Barringer M et al.: Assessing Alzheimer severity with a global clinical scale. Int. Psychogeriatr. 4(1), 55-74 (1992).
49. Molloy DW, Alemayehu E, Roberts R: Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination. Am. J. Psychiatry 148(1), 102-105 (1991).
50. Teng EL, Chui HC: The Modified Mini-Mental State (3MS) examination. J. Clin. Psychiatry 48(8), 314-318 (1987).
51. Braekhus A, Laake K,Engedal K: The Mini-Mental State Examination: identifying the most efficient variables for detecting cognitive impairment in the elderly. J. Am. Geriatr. Soc. 40(11), 1139-1145 (1992).
52. Stuss DT, Meiran N, Guzman DA, Lafleche G, Willmer J: Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests. Arch. Neurol. 53(10), 1033-1039 (1996).
53. Ashford JW, Schmitt FA: Modeling the time-course of Alzheimer dementia. Curr. Psychiatry Rep. 3(1), 20-28 (2001).
54. Panisset M, Roudier M, Saxton J, Boller F: Severe impairment battery. A neuropsychological test for severely demented patients. Arch. Neurol. 51(1), 41-45 (1994).
55. Schmitt FA, Ashford W, Ernesto C et al.: The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 11(Suppl. 2), S51-S56 (1997).
56. Beck CK, Frank LB: Assessing functioning and self-care abilities in Alzheimer disease research. Alzheimer Dis. Assoc. Disord. 11(Suppl. 6), 73-80 (1997).
57. Karagiozis H, Gray S, Sacco J, Shapiro M, Kawas C: The Direct Assessment of Functional Abilities (DAFA): a comparison to an indirect measure of instrumental activities of daily living. Gerontologist 38(1), 113-121 (1998).
58. Loewenstein DA, Amigo E, Duara R et al.: A new scale for the assessment of functional status in Alzheimer's disease and related disorders. J. Gerontol. 44(4), P114-P121 (1989).
59. Stahelin HB, Monsch AU, Spiegel R: Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int. Psychogeriatr. 9(Suppl. 1), 123-130 (1997).
60. Hayden KM, Khachaturian AS, Tschanz JT et al.: Characteristics of a two-stage screen for incident dementia. J. Clin. Epidemiol. 56(11), 1038-1045 (2003).
61. Ashford JW, Jarvik L: Alzheimer's disease: does neuron plasticity predispose to axonal neurofibrillary degeneration? N. Engl. J. Med. 313(6), 388-389 (1985).
62. Ashford JW, Soultanian NS, Zhang SX. Geddes JW: Neuropil threads are colinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain. J. Neuropathol. Exp. Neurol. 57(10), 972-978 (1998).
63. Teter B, Ashford JW: Neuroplasticity in Alzheimer's disease. J. Neurosci. Res. 70(3), 402-437 (2002).
64. Ashford JW, Mattson M, Kumar V: Neurobiological systems disrupted by Alzheimer's disease and molecular biological theories of vulnerability. In: Advances in the Diagnosis and Treatment of Alzheimer's Disease. Springer Publishing Company, NY, USA (1998).
65. Martin A, Brouwers P, Cox C, Fedio P: On the nature of the verbal memory deficit in Alzheimer's disease. Brain Lang. 25(2), 323-341 (1985).
66. Knopman DS, Ryberg S: A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch. Neurol. 46(2), 141-145 (1989).
67. Borson S, Brush M, Gil E et al.: The Clock Drawing Test: utility for dementia detection in multiethnic elders. J. Gerontol. A Biol. Sci. Med. Sci. 54(11), M534-M540 (1999).
68. Monsch AU, Bondi MW, Butters N et al.: Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch. Neurol. 49(12), 1253-1258 (1992).
69. Weingartner HJ, Kawas C, Rawlings R, Shapiro M: Changes in semantic memory in early stage Alzheimer's disease patients. Gerontologist 33(5), 637-643 (1993).
70. Solomon PR, Hirschoff A, Kelly B et al.: A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch. Neurol. 55(3), 349-355 (1998).
71. Robert PH, Schuck S, Dubois B et al.: Screening for Alzheimer's disease with the short cognitive evaluation battery. Dement. Geriatr. Cogn. Disord. 15(2), 92-98 (2003).
72. Beinhoff U, Hilbert V, Bittner D, Gron G, Riepe MW: Screening for cognitive impairment: a triage for outpatient care. Dement. Geriatr. Cogn. Disord. 20(5), 278-285 (2005).
73. Dash P, Troupin A, Thomsen JMK: The Q&E is more sensitive than the Clock Draw, Mini-cog, and 6-item screener in the detection of mild Alzheimer s disease (AD). Alzheimers Dement. 1(1 Suppl. 1), 90 (2005).
74. Chopra A, Cavalieri T, Libon D: Dementia screening tools for the primary care physician. Clin Geriatrics 15(1), 38-45 (2007).
75. Salmon DP, Thomas RG, Pay MM et al.: Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology 59(7), 1022-1028 (2002).
76. Buschke H, Kuslansky G, Katz M et al.: Screening for dementia with the memory impairment screen. Neurology 52(2), 231-238 (1999).
77. Kuslansky G, Buschke H, Katz M, Sliwinski M, Lipton RB: Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J. Am. Geriatr. Soc. 50(6), 1086-10891 (2002).
78. Buschke H, Sliwinski MJ, Kuslansky G, Lipton RB: Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity. Neurology 48(4), 989-997 (1997).
79. Rey A: L'examen Clinique en Psychologie. Press Universitaire de France, Paris (1958).
80. Visser PJ, Verhey FR, Ponds RW, Jolles J: Diagnosis of preclinical Alzheimer's disease in a clinical setting. Int. Psychogeriatr. 13(4), 411-423 (2001).
81. Estevez-Gonzalez A, Kulisevsky J, Boltes A, Otermin P, Garcia-Sanchez C: Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging. Int. J. Geriatr. Psychiatry 18(11), 1021-1028 (2003).
82. Tierney MC, Yao C, Kiss A, McDowell I: Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64(11), 1853-1859 (2005).
83. Shankle WR, Romney AK, Hara J et al.: Methods to improve the detection of mild cognitive impairment. Proc Natl Acad. Sci. USA 102(13), 4919-24 (2005).
84. Benton AL: The visual retention test as a constructional praxis task. Confin. Neurol. 22, 141-155 (1962).
85. Kawas CH, Corrada MM, Brookmeyer R et al.: Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology 60(7), 1089-1093 (2003).
86. Lindeboom J, Schmand B, Tulner L, Walstra G, Jonker C: Visual association test to detect early dementia of the Alzheimer type. J. Neurol. Neurosurg. Psychiatry 73(2), 126-33 (2002).
87. Fillenbaum GG, Wilkinson WE, Welsh KA, Mohs RC: Discrimination between stages of Alzheimer's disease with subsets of Mini-Mental State Examination items. An analysis of Consortium to Establish a Registry for Alzheimer's Disease data. Arch. Neurol. 51(9), 916-921 (1994).
88. Ashford JW, Shan M, Butler S, Rajasekar A, Schmitt FA: Temporal quantification of Alzheimer's disease severity: 'time index' model. Dementia 6(5), 269-280 (1995).
89. Ashford JW, Schmitt F, Kumar V: Diagnosis of Alzheimer's disease. In: Advances in the Diagnosis and Treatment of Alzheimer's Disease. Springer Publishing Company, NY, USA (1998).
90. Teresi JA, Golden RR, Cross P et al.: Item bias in cognitive screening measures: comparisons of elderly white, Afro-American, Hispanic and high and low education subgroups. J. Clin. Epidemiol. 48(4), 473-483 (1995).
91. Schmitt FA, Mendiondo MS, Kryscio RJ, Ashford JW: A brief Alzheimer's screen for clinical practice. Res. Pract. Alzheimers Dis. 11, 1-4 (2006).
92. Tierney MC, Szalai JP, Dunn E, Geslani D, McDowell I: Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Value of the Mini-Mental State Examination. Arch. Fam. Med. 9(6), 527-532 (2000).
93. Reitan RM: The relation of the trail making test to organic brain damage. J. Consult. Psychol. 19(5), 393-394 (1955).
94. Chen P, Ratcliff G, Belle SH et al.: Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch. Gen. Psychiatry 58(9), 853-858 (2001).
95. Chen P, Ratcliff G, Belle SH et al.: Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 55(12), 1847-1853 (2000).
96. Elias MF, Beiser A, Wolf PA et al.: The preclinical phase of alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch. Neurol. 57(6), 808-813 (2000).
97. Markesbery WR, Schmitt FA, Kryscio RJ et al.: Neuropathologic substrate of mild cognitive impairment. Arch. Neurol. 63(1), 38-46 (2006).
98. Ohm TG, Muller H, Braak H, Bohl J: Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 64(1), 209-217 (1995).
99. Schmitt FA, Davis DG, Wekstein DR et al.: 'Preclinical' AD revisited: neuropathology of cognitively normal older adults. Neurology 55(3), 370-6 (2000).
100. Woodard JL, Auchus AP, Godsall RE, Green RC: An analysis of test bias and differential item functioning due to race on the Mattis Dementia Rating Scale. J. Gerontol. B Psychol. Sci. Soc. Sci. 53(6), P370-P374 (1998).
101. Kraemer HC, Taylor JL, Tinklenberg JR, Yesavage JA: The stages of Alzheimer's disease: a reappraisal. Dement. Geriatr. Cogn. Disord. 9(6), 299-308 (1998).
102. Mitrushina M, Satz P: Test-retest reliability of the WAIS-R Satz-Mogel short form in a normal elderly sample. Aging (Milano) 8(4), 250-253 (1996).
103. Mungas D, Reed BR: Application of item response theory for development of a global functioning measure of dementia with linear measurement properties. Stat. Med. 19(11-12), 1631-1644 (2000).
104. Helme, E, Merskey H, Hachinski VC, Wands K: An examination of psychometric properties of the attended scale for dementia in three different populations. Alzheimer Dis. Assoc. Disord. 6(4), 236-246 (1992).
105. Ashford JW, Shih WJ, Coupal J et al.: Single SPECT measures of oerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer's disease. J. Nucl. Med. 41(1), 57-,64 (2000).
106. Small GW, Kepe V, Erooli LM et al.: PET of brain amyloid and tau in mild cognitive impairment. N. Engl. J. Med. 355(25), 2652-2663 (2006).
107. Teresi JA: Mini-Mental State Examination (MMSE): scaling the MMSE using item response theory (IRT). J. Clin. Epidemiol. 60(3), 256-259 (2007).
108. Schultz-Larsen K, Kreiner S, Lomholt RK: Mini-Mental Status Examination: mixed Rasch model item analysis derived two diffierent cognitive dimensions of the MMSE. J. Clin. Epidemiol. 60(3), 268-279 (2007).
109. Tierney MC, Herrmann N, Geslani DM, Szalai JP: Contribution of informant and patient ratings to the accuracy of the minimental state examination in predicting probable Alzheimer's disease. J. Am. Geriatr. Soc. 51(6), 813-818 (2003).
110. Reisberg B, Ferris SH, de Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139(9), 1136-1139 (1982).
111. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL: A new clinical scale for the staging of dementia. Br. J. Psychiatry 140, 566-572 (1982).
112. Berg L: Clinical Dementia Rating. Br. J. Psychiatry 145, 339 (1984).
113. Reisberg B, Ferris SH: Brief Cognitive Rating Scale (BCRS). Psychopharmacol. Bull. 24(4), 629-636 (1988).
114. Brodaty H, Pond D, Kemp NM et al.: The GPCOG: a new screening test for dementia designed for general practice. J. Am. Geriatr. Soc. 50(3), 530-534 (2002).
115. Brodaty H, Low LF, Gibson L, Burns K: What is the best dementia screening instrument for general practitioners to use? Am. J. Geriatr. Psychiatry 14(5), 391-400 (2006).
116. Holsinger T, Deveau J, Boustard M, Williams JW Jr. Does this patient have dementia? JAMA 297(21), 2391-2404 (2007).
117. Cullen B, O'Neill B, Evans JJ, Coen RF, Lawlor BA: A review of screening tests for cognitive impairment. J. Neurol. Neurosurg. Psychiatry 78(8), 790-799 (2007).
118. Milne A, Culverwell A, Guss R, Tuppen J, Whelton R: Screening for dementia in primary care: a review of the use, efficacy and quality of measures. Int. Psychogeriatr. 1-16 (2008).
119. Barratt A, Irwig L, Glasziou P et al.: Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA 281(21), 2029-2034 (1999).
120. Kraemer H: Evaluating Medical Tests. Sage Publications, Inc., Newbury Park CA, USA (1992).
121. Jorm AF, Jolley D: The incidence of dementia: a meta-analysis. Neurology 51(3), 728-733 (1998).
122. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A: Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 54(11), 2072-2077 (2000).
123. Ashford JW: APOE genotype effects on Alzheimer's disease onset and epidemiology. J. Mol. Neurosci. 23(3), 157-165 (2004).
124. Ashford JW, Mortimer JA: Non-familial Alzheimer's disease is mainly due to genetic factors. J. Alzheimers Dis. 4(3), 169-177 (2002).
125. O'Hara R, Sommer B, Way N et al.: Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele. J. Psychiatr. Res. 42 (3), 199-204 (2008).
126. Corder EH, Saunders AM, Strittmatter WJ et al.: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261(5123), 921-923 (1993).
127. Breitner JC, Wyse BW, Anthony JC et al.: APOE-ε4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 53(2), 321-331 (1999).
128. Raber J, Huang Y Ashford JW: ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging 25(5), 641-650 (2004).
129. Nussbaum RL, Ellis CE: Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348(14), 1356-1364 (2003).
130. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39(1), 17-23 (2007).
131. Geddes JW, Tekirian TL, Soultanian NS et al.: Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol. Aging 18(4 Suppl.), S99-S105 (1997).
132. Schneider JA, Arvanitakis Z, Bang W, Bennett DA: Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69(24), 2197-2204 (2007).
133. Tinklenberg JR, Kraemer HC, Yaffe K et al.: Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice? Am J. Geriatr. Psychiatry 15(11), 953-960 (2007).
134. Knopman D, Schneider L, Davis K et al.: Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group. Neurology 47(1), 166-177 (1996).
135. Provenzano G, Duttagupta S, McRae T et al.: Delays in nursing home placement for patients with alzheimer's disease associated with donepezil may have health care cost saving implications. Value Health 4(2), 155-156 (2001).
136. Ashford JW, Schmitt FA, Kumar V: Diagnosis of Alzheimer's Disease. Psychiatrn Ann. 26(5), 262-268 (1996).
137. Knopman DS, DeKosky ST, Cummings JL et al.: Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56(9), 1143-1153 (2001).
138. Burns A, Lawlor B, Craig S (Eds).: Assessment Scales in Old Age Psychiatry. Martin Dunitz Ltd, London, UK (1999).
139. Petersen RC, Stevens JC, Ganguli M et al.: Practice parameter early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56(9), 1133-1142 (2001).
140. Galluzzi S, Cimaschi L, Ferrucci L, Frisoni GB: Mild cognitive impairment: clinical features and review of screening instruments. Aging (Milano) 13(3), 183-202 (2001).
141. Lorentz WJ, Scanlan JM, Borson S: Brief screening tests for dementia. Can. J. Psychiatry 47(8), 723-733 (2002).
142. Solomon PR Murphy CA: Should we screen for Alzheimer's disease? A review of the evidence for and against screening Alzheimer's disease in primary care practice. Geriatrics 60(11), 26-31 (2005).
143. Shulman KI, Herrmann N, Brodaty H et al.: IPA survey of brief cognitive screening instruments. Int. Psychogeriatr. 18(2), 281-94 (2006).
144. Borson S, Scanlan J, Hummel J et al.: Implementing routine cognitive screening of older adults in primary care: process and impact on physician behavior. J. Gen. Intern. Med. 22(6), 811-817 (2007).
145. Rentz D, Weintraub S: Neuropsychological detection of early probable Alzheimer's disease. In: Early Diagnosis of Alzheimer's Disease. Humana Press, Totowa, NJ, USA 169-189 (2000).
146. Brayne C, Fox C, Boustani M: Dementia screening in primary care: is it time? JAMA 298(20), 2409-2411 (2007).
147. Ashford JW, Borson S: Primary care screening for dementia and mild cognitive impairment. JAMA 299(10), 1132-1133; author reply 1133-1134 (2008).
148. Jansen AP, van Hout HP, Nijpels G et al.: Yield of a new method to detect cognitive impairment in general practice. Int. J. Geriatr. Psychiatry 22(6), 590-597 (2007).
149. Kapp MB: Should home screening tests for Alzheimer's disease be regulated? Gerontologist 43(3), 292-294 (2003).
150. Ashford JW, Coburn VL, Yamashita K: P300 Power loss in aging and Alzheimer's disease. Presented at: Society for Neuroscience, Annual Meeting. Anaheim, CA, USA (1992).
151. Coburn KL, Ashford JW, Moreno MA: Visual evoked potentials in dementia: selective delay of flash P2 in probable Alzheimer's diseaseJ. Neuropsychiatry Clin. Neurosci. 3(4), 431-435 (1991).
152. Gironell A, Garcia-Sanchez C, Estevez-Gonzalez A, Boltes A, Kulisevsky J: Usefulness of p300 in subjective memory complaints: a prospective study. J. Clin. Neurophysiol. 22(4), 279-284 (2005).
153. Lawrence JM, Davidoff DA, Katt-Lloyd D et al.: Is large-scale community memory screening feasible? Experience from a regional memory-screening day. J. Am. Geriatr. Soc. 51(8), 1072-1078 (2003).
154. Perez FI, Hruska NA, Stell RL, Rivera VM: Computerized assessment of memory performance in dementia. Can. J. Neurol. Sci 5(3), 307-312 (1978).
155. Larrabee GJ, Crook T: A computerized everyday memory battery for assessing treatment effects. Psychopharmacol. Bull. 24(4), 695-697 (1988).
156. Green RC, Green J, Harrison JM, Kutner MH: Screening for cognitive impairment in older individuals. Validation study of a computer-based test. Arch. Neurol. 51(8), 779-786 (1994).
157. Elwood RW: MicroCog: assessment of cognitive functioning. Neuropsychol. Rev. 11(2), 89-100 (2001).
158. Erlanger DM, Kaushik T, Broshek D et al.: Development and validation ofa web-based screening tool for monitoring cognitive status. J. Head Trauma Rehabil. 17(5), 458-476 (2002).
159. Paul RH, Lawrence J, Williams LM et al.: Preliminary validity of 'integneur': a new computerized battery of neurocognitive tests. Int. J. Neurosci. 115(11), 1549-1567 (2005).
160. Tornatore JB, Hill E, Laboff JA, McGann ME: Self-administered screening for mild cognitive impairment: initial validation of a computerized test battery J. Neuropsychiatry Clin. Neurosci. 17(1), 98-105 (2005).
161. Ashford J: MemTrax (Computerized Memory Screen). Presented at: The American Association for Geriatric Psychiatry Annual Meeting. New Orleans, LA, USA, 1-4 March (2007).
162. Withers E, Hinton J: Three forms of the clinical tests of the sensorium and their reliability. Br. J. Psychiatry 119(548), 1-8 (1971).
163. Kastenhaum RSS: VIRO, a scale for assign the interview behavior. In: Research Planning and Action for the Elderly, the Power and Potential of Social Science. Behavioral Publications, New York, NY, USA 166-200 (1972).
164. Shapiro MB, Post F, Lofving B Inglis J: Memory function in psychiatric patients over sixty, some methodological and diagnostic implications. J. Ment. Sci. 102(427), 233-46 (1956).
165. Smith A: The serial sevens subtraction test. Arch. Neurol. 17(1), 78-80 (1967).
166. Penfield W Roberts L: Speech and Brain-Mechanism. Princeton University Press, Princeton, NJ, USA (1959).
167. Schuell H: A short examination for aphasia. Neurology 7(9), 625-634 (1957).
168. Geschwind N: The organization of language and the brain. Science 170(961), 940-494 (1970).
169. Klein R, Mayer-Gross W: The Clinical Examination Of Patients With Organic Cerebral Disease. Cassell, London, UK (1957).
170. Pattie AH: A survey version of the Clifton Assessment Procedures for the Elderly (CAPE). Br. J. Clin. Psychol. 20(Pt 3), 173-178 (1981).
171. Katzman R, Brown T, Fuld P et al.: Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am. J. Psychiatry 140(6), 734-739 (1983).
172. Eslinger PJ, Damasio AR, Benton AL, Van Allen M: Neuropsychologic detection of abnormal mental decline in older persons. JAMA 253(5), 670-674 (1985).
173. Kokmen E, Naessens JM, Offord KP: A short test of mental status: description and preliminary results. Mayo Clin. Proc. 62(4), 281-288 (1987).
174. Weintraub S, Peavy GM, O'Connor M et al.: Three words three shapes: a clinical test of memory. J. Clin. Exp. Neuropsychol. 22(2), 267-278 (2000).
175. Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC: Six-item screener to identify cognitive impairment among potential subjects fbr clinical research. Med. Care 40(9), 771-781 (2002).
176. Karlawish JH, Clark CM: Diagnostic evaluation of elderly patient with mild memory problems. Ann. Intern. Med. 138(5), 411-419 (2003).
177. Borson S, Scanlan JM, Chen P, Ganguli M: The Mini-Cog as a screen for dementia: validation in a population-based sample. J. Am. Geriatr. Soc. 51(10), 1451-1454 (2003).
178. Kalbe E, Calabrese P, Schwalen S, Kessler J: The Rapid Dementia Screening Test (RDST): a new economical tool for detecting possible patients with dementia. Dement. Geriatr. Cogn. Disord. 16(4), 193-199 (2003).
179. Molloy DW, Standish TI, Lewis DL: Screening for mild cognitive impairment. comparing the SMMSE and the ABCS. Can. J. Psychiatry 50(1), 52-58 (2005).
180. Kilada S, Gamaldo A, Grant EA et al.: Brief screening tests for the diagnosis of dementia: comparison with the mini-mental state exam. Alzheimer Dis. Assoc. Disord. 19(1), 8-16 (2005).
181. Tractenberg RE, Aisen PS, Chuang YL: One-trial 10-item free-recall performance in Taiwanese elderly and near-elderly: a potential screen for cognitive decline. Am. J. Alzheimers Dis. Other Demen. 20(4), 239-247 (2005).
182. Meer B, Baker JA: The Stockton Geriatric Rating Scale. J. Gerontol. 21(3), 392-403 (1966).
183. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3), 179-186 (1969).
184. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S: Measurement of functional activities in older adults in the community. J. Gerontol. 37(3), 323-329 (1982).
185. Schwartz GE: Development and validation of the geriatric evaluation by relatives rating instrument (GERRI). Psychol. Rep. 53(2), 479-88 (1983).
186. Weintraub S: The record of independent living: An informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am. J. Alzheimers Dis. 1(2), 35-39 (1986).
187. Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol. Med. 19(4), 1015-1022 (1989).
188. Summers WK, DeBoynton V, Marsh GM, Majovski LV: Comparison of seven psychometric instruments used for evaluation of treatment effect in Alzheimer's dementia. Neuroepidemiology 9(4), 193-207 (1990).
189. Teunisse S, Derix MM: Measurement of activities of daily living in patients with dementia living at home: development of a questionnaire. Tijdschr. Gerontol. Geriatr. 22(2), 53-59 (1991).
190. Spiegel R, Brunner C, Ermini-Funfschilling D et al.: A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients). J. Am. Geriatr. Soc. 39(4), 339-347 (1991).
191. Goldman HH, Skodol AE, Lave TR: Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatry 149(9), 1148-1156 (1992).
192. Burns T, Mortimer JA, Merchak P: Cognitive Performance Test: a new approach to functional assessment in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 7(1), 46-54 (1994).
193. Ritchie K, Fuhrer R: A comparative study of the performance of screening tests for senile dementia using receiver operating characteristics analysis. J. Clin. Epidemiol. 45(6), 627-637 (1992).
194. Artero S, Ritchie K: The detection of mild cognitive impairment in the general practice setting. Aging Ment. Health 7(4), 251-258 (2003).
195. Galasko D, Bennett D, Sano M et al.: An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis. Assoc. Disord. 11 (Suppl. 2), S33-S39 (1997).
196. Morris JN, Fries BE, Mehr DR et al.: MDS Cognitive Performance Scale. J. Gerontol. 49(4), M174-M182 (1994).
197. Kempen GI, Miedema I, Ormel J, Molenaar W: The assessment of disability with the Groningen Activity Resuriction Scale. Conceptual framework and psychometric properties. Soc. Sci. Med. 43(11), 1601-1610 (1996).
198. Drachman DA, Swearer JM, Kane K et al.: The cognitive assessment screening test (CAST) for dementia. J. Geriatr. Pychiatry Neurol. 9(4), 200-208 (1996).
199. Gelinas I, Gauthier L, McIntyre M, Gauthier S: Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am. J. Occup. Ther. 53(5), 471-481 (1999).
200. Mundt JC, Freed DM, Greist JH: Lay person-based screening for early detection of Alzheimer's disease: development and validation of an instrument. J. Gerontol. B Pychol. Sci. Soc. Sci. 55(3), P163-170 (2000).
201. Hopman-Rock M, Tak EC, Staats PG: Development and validation of the Observation List for early signs of Dementia (OLD). Int. J. Geriatr. Psychiatry 16(4), 406-414 (2001).
202. Griffith HR, Belue K, Sicola A et al.: Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 60(3), 449-457 (2003).
203. Solomon P, Ruiz M, Murphy C: The Alzheimers Disease Caregiver Questionnaire: Initial validation of a screening instrument. Int. Psychogeriatr. 15(Suppl. 2), 87 (2003).
204. Johnson N, Barion A, Rademaker A, Rehkemper G, Weintraub S: The Activities of Daily Living Questionnaire: a validation study in patients with dementia. Alzheimer Dis. Assoc. Disord. 18(4), 223-230 (2004).
205. Galvin JE, Roe CM, powlishta KK et al.: The AD8: a brief informant interview to detect dementia. Neurology 65(4), 559-564 (2005).
206. Frank L, Flynn JA, Kleinman L et al.: Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment. Int. Pychogeriatr. 18(1), 135-149 (2006).
207. Berg L, Miller JP, Storandt M et al.: Mild senile dementia of the Alzheimer type 2. Longitudinal assessment. Ann. Neurol. 23(5), 477-84 (1988).
208. Reisberg B: Functional assessment staging (FAST). Psychopharmacol. Bull. 24(4), 653-659 (1988).
209. Inouye SK, van Dyck CH, Alessi CA et al.: Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann. Intern. Med. 113(12), 941-948 (1990).
210. Brazzelli M, Capitani E, Della Sala S, Spinnler H, Zuffi M: A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment. J. Neurol. Neurosurg. Psychiatry 57(12), 1510-1517 (1994).
211. Mackinnon A, Mulligan R: Combining cognitive testing and informant report to increase accuracy in screening for dementia. Am. J. Psychiatry 155(11), 1529-1535 (1998).
212. Brandt J, Spencer M, Folstein M: The telephone interview for cognitive status. Neuropsychiatry Neuropsychol. Behav. Neurol. 1(1), 111-117 (1988).
213. Lanska DJ, Schmitt FA, Stewart JM, Howe JN: Telephone-Assessed Mental State. Dementia 4(2), 117-119 (1993).
214. Gatz M, Reynolds C, Nikolic J et al.: An empirical test of telephone screening to identify potential dementia cases. Int. Psychogeriatr. 7(3), 429-438 (1995).
215. Gatz M, Reynolds CA, John R et al.: Telephone screening to identify potential dementia cases in a population-based sample of older adults. Int. Psychogeriatr. 14(3), 273-289 (2002).
216. Knopman DS, Knudson D, Yoes ME, Weiss DJ: Development and standardization of a new telephonic cognitive screening test: the Minnesota Cognitive Acuity Screen (MCAS). Neuropsychiatry Neuropsychol. Behav. Neurol. 13(4), 286-296 (2000).
217. Mundt JC, Ferber KL, Rizzo M, Greist JH: Computer-automated dementia screening using a touch-tone telephone. Arch. Intern. Med. 161(20), 2481-2487 (2001).
218. Lipton RB, Katz MJ, Kuslansky G et al.: Screening for dementia by telephone using the memory impairment screen. J. Am. Geriatr. Soc. 51(10), 1382-90 (2003).
219. Newkirk LA, Kim JM, Thompson JM et al.: Validation of a 26-point telephone version of the Mini-Mental State Examination. J. Geriatr. Psychiatry Neurol. 17(2), 81-87 (2004).
220. Hill J, McVay JM, Walter-Ginzburg A et al.: Validation of a brief screen for cognitive impairment (BSCI) administered by telephone for use in the medicare population. Dis. Manag. 8(4), 223-234 (2005).
221. Unverzagt FW, Monahan PO, Moser LR et al.: The Indiana University telephone-based assessment of neuropsychological status: a new method for large scale neuropsychological assessment. J. Int. Neuropsychol. Soc. 13 (5), 799-806 (2007).
222. Dwolatzky T, Whitehead V, Doniger GM et al.: Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment. J. Mol. Neurosci. 24(1), 33-44 (2004).
223. Benton AL, Vanallen MW, Fogel ML: Temporal orientation in cerebral disease. J. Nerv. Ment. Dis. 139, 110-119 (1964).
224. Borkowski JG, Benton AL, Spreen O: Word fluency and brain damage. Neuropsychologia 6, 135-140 (1967).
225. Isaacs B, Kennie AT: The Set test as an aid to the detection of dementia in old people. Br. J. Psychiatry 123(575), 467-470 (1973).
226. Critchley M: The Parietal Lobes. Hafner, NY, USA (1953).
227. South MB, Greve KW, Bianchini KJ, Adams D: Interrater reliability of three clock drawing test scoring systems. Appl. Neuropsychol. 8(3), 174-179 (2001).
228. Jones BN, Teng EL, Folstein MF, Harrison KS: A new bedside test of cognition. for patients with HIV infection. Ann. Intern. Med. 119(10), 1001-1004 (1993).
229. Froehlich TE, Robison JT, Inouye SK: Screening for dementia in the outpatient setting: the time and change test. J. Am. Geriatr. Soc. 46(12), 1506-1511 (1998).
230. Inouye SK, Robison JT, Froehlich TE, Richardson ED: The time and change test. a simple screening test for dementia. J. Gerontol. A Biol. Sci. Med. Sci. 53(4), M281-M286 (1998).
231. Leopold NA, Borson AJ: An alphabetical 'WORLD'. A new version of an old test. Neurology 49(6), 1521-1524 (1997).
232. Jacobs JW, Bernhard MR, Delgado A, Strain JJ: Screening for organic mental syndromes in the medically ill. Ann. Intern. Med. 86(1), 40-46 (1977).
233. Hersch EL: Development and application of the extended scale for dementia. J. Am. Geriatr. Soc. 27(8), 348-354 (1979).
234. Lau C, Wands Y, Merskey H et al.: Sensitivity and specificity of the amended scale for dementia. Arch. Neurol. 45(8), 849-852 (1988).
235. Mayeux R, Stern Y, Rosen J, Leventhal J: Depression, intellectual impairment, and Parkinson disease. Neurology 31(6), 645-650 (1981).
236. Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y: Questionable dementia: clinical course and predictors of outcome. J. Am. Geriatr. Soc. 45(3), 321-328 (1997).
237. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am. J. Psychiatry 141(11), 1356-1364 (1984).
238. Roth M, Tym E, Mountjoy CQ et al.: CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149, 698-709 (1986).
239. Kiernan RJ, Mueller J, Langston JW, Van Dyke C: The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann. Intern. Med. 107(4), 481-485 (1987).
240. Faust D, Fogel BS: The development and initial validation of a sensitive bedside cognitive screening test. J. Nerv. Ment. Dis. 177(1), 25-31 (1989).
241. Fisk J, Braha R, Walker A, Gray J: The Halifax Mental Status Scale: deevelopment of a new test of mental status for use with elderly clients. Psychol. Assess. J. Consult. Clin. Psychol. 3, 162-167 (1991).
242. Fisk J, Rockwood K, Hondas B et al.: Cognitive screening in a population-based sample of community-living elderly: effects of age and education on the construct of cognitive status. Int. J. Geriatr. Psychiatry 10, 687-694 (1995).
243. Meiran N, Stuss DT, Guzman DA, Lafleche G, Willmer J: Diagnosis of dementia. Methods for interpretation of scores of 5 neuropsychological tests. Arch. Neurol. 53(10), 1043-1054 (1996).
244. Randolph C, Tierney MC, Mohr E, Chase TN: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20(3), 310-319 (1998).
245. Yokota M, Miyanaga K, Yonemura K et al.: Declining of memory functions of normal elderly persons. Psychiatry Clin. Neurosci. 54(2), 217-225 (2000).
246. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR: A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 55(11), 1613-1620 (2000).
247. Belle SH, Mendelsohn AB, Seaberg EC, Ratcliff G: A brief cognitive screening battery for dementia in the community. Neuroepidemiology 19(1), 43-50 (2000).
248. Banks WA, Morley JE: Memories are made of this: recent advances in understanding cognitive impairments and dementia. J. Gerontol. A Biol. Sci. Med. Sci. 58(4), 314-321 (2003).
249. Storey JE, Rowland JT, Basic D, Conforti DA, Dickson HG: The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int. Psychogeriatr. 16(1), 13-31 (2004).
250. Kalbe E, Kessler J, Calabrese P et al.: DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int. J. Geriatr. Psychiatry 19(2), 136-143 (2004).
251. Nasreddine ZS, Phillips NA, Bedirian V et al.: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53(4), 695-699 (2005).
252. Weintraub S: Neuropsychological assessment of mental state. In: Principles of Behavioral and Cognitive Neurology (2nd Edition). Oxford University Press, New York, NY, USA 121-173 (2000).
253. Cummings J: The Neuropsychiatry of Alzheimer's Disases and Related Dementias. Martin Dunitz Ltd, Taylor and Francis Group, London, UK (2003).
254. Lezak M, Howlieson D, Loring D: Neuropsychological Assessment (5th Edition). Oxford University Press, New York, NY, USA, (2004).
255. Strauss E, Sherman E, Spreen O: A Compendium of Neuropsychological Tests, Administration, Norms, and Commentary (3rd Edition). Oxford University Press, NY, USA (2006).
256. Wechsler D: Manual for the Wechsler Adult Intelligence Scale: Revised. Psychological Corporation, San Antonio, TX, USA (1987).
257. Morris JC, Heyman A, Mohs RC et al.: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39(9), 1159-1165 (1989).
258. Harrison J, Minassian SL, Jenkins L et al.: A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch. Neurol. 64(9), 1323-9 (2007).
259. Larrabee GJ, Curtiss G: Construct validity of various verbal and visual memory tests. J. Clin. Exp. Neuropsychol. 17(4), 536-547 (1995).
260. Ray S, Britschgi M, Herbert C et al.: Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 13(11), 1359-1362 (2007).